Significant Antitrust Issues for Healthcare & Pharma Industries: What Lies Ahead in 2018 & Beyond
For the past years, healthcare and pharma professionals have given careful considerations and importance to antitrust enforcement and fair competition. However, because of the complex and ever evolving laws applying to the healthcare and pharma industries, practitioners have been continually posed with significant challenges, such as keeping themselves abreast of the different legal and regulatory updates to avoid greater exposures to the risks and perils of antitrust liabilities.
Listen as a panel of distinguished professionals and practitioners organized by The Knowledge Group provide the audience with an in-depth analysis of the recent developments and potential changes involving antitrust in the healthcare and pharma industries. Speakers, among other things, will discuss the latest and most significant antitrust enforcement, litigation and policy issues.
In a LIVE webcast, the speakers will discuss:
- Antitrust Laws in Healthcare and Pharma Industries
- Recent Antitrust Enforcements
- Strategies in Avoiding Risks and Liabilities
- Updates in Antitrust Litigation
- Trends and Developments in 2018
Noah Pinegar, Attorney
Paul Hastings LLP
- Trump antitrust enforcement update:
- Old “rules” don’t apply, I’ll tell you why
- Major pharmacies/PBMs make big moves
- Pharma Litigation Update
- Biologics and antitrust—what the early innings tell us
Dr. Samuel Weglein, Principal
- COPAs and CON regulations
- Occupational licensing
- Anti-steering and narrow networks
- Drug couponing
Dr. Fabian Leimgruber LL.M, Partner
- Healthcare and Pharma Antitrust Developments in the Globalized Market in 2018 and beyond
- Global monitoring and surveillance systems for Pharma IP-related issues
- Record fines in abuse and dominance in the pharma sector
- Developments in procedural infringements in antitrust inquiries
- Quo vadis? How far can Healthcare and Pharma Antitrust Laws go to be distorted from Antitrust Laws of the general economics?
Who Should Attend:
- Antitrust Lawyers
- Pharmaceutical and Healthcare Industries
- General Counsel in Life Sciences and Healthcare Industries
- Pharma/Healthcare Attorneys & Advisors
- Compliance Officers
- Other related/interested Professionals and Organization
Noah Pinegar is an associate in the antitrust practice of Paul Hastings LLP where he represents clients in deals before the US DOJ, Federal Trade Commission, and foreign competition authorities, as well as in antitrust/competition and related litigation. Noah spent three years in the FTC, Mergers I division, which investigates deals in pharmaceuticals, pharmacies and PBMs, medical devices, and related industries. His experience includes litigated merger matters, and numerous high-profile investigations, both from the enforcement side and as counsel to private parties.
Noah Pinegar is an associate in the antitrust practice of Paul Hastings LLP where he represents clients in deals before …
Dr. Weglein specializes in applying economics, statistics, and valuation to the analysis of liability issues and damages in antitrust, finance and securities, and general business litigation matters. He has worked on numerous antitrust cases, including the proposed merger of Anthem and Cigna, private litigation brought by health care providers against payors, and a number of government actions in provider markets. In addition, he worked on behalf of Microsoft in several consumer and competitor actions, managing teams that supported damages experts. He has also assisted with antitrust litigation in a number of financial benchmark cases, including LIBOR and foreign exchange matters, as well as in a private equity related antitrust case. Dr. Weglein has coauthored a number of publications, and has testified on damages in a major arbitration case in the shipping industry.
Dr. Weglein specializes in applying economics, statistics, and valuation to the analysis of liability issues and damages in antitrust, finance …
Fabian Leimgruber is a pre-eminent lawyer and senior patent attorney, who has earned a reputation as first-rate litigator and patent prosecutor mainly in the fields of software, business methods, chemistry and life science, competition and license law. Fabian is a senior partner at ThomannFischer Law Firm with many years of experience in various large Law Firms. One of Fabian’s specific area of expertise is the leading and implementation of international patent infringement and competition law litigations. He handles patent cases in all Swiss and German Courts and the European Patent Office. Fabian has run several of the largest patent cases involving patents and standards in recent years. Further, he represents clients in front of arbitral tribunals and the national and international patent offices, opposition and appeal divisions. Fabian has a double degree in physics (Ph.D.) and law (Juris Doctor). A graduate of the University of Basel (Switzerland), CERN in Geneva, University of Freiburg (Germany), National University of Singapore (LL.M.) and East China University of Political Science and Law, Fabian joined ThomannFischer Law Firm in 2012 to help establish the firm’s modern approach to IP practice and litigation.
Fabian Leimgruber is a pre-eminent lawyer and senior patent attorney, who has earned a reputation as first-rate litigator and patent …
Print and review course materials
Method of Presentation:
Experience in antitrust laws
NY Category of CLE Credit:
Areas of Professional Practice
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
Get Your 1-Year All Access Pass For Only $199
About Paul Hastings LLP
Paul Hastings Antitrust and Competition practice represent many of the world’s leading business and financial enterprises in their most significant antitrust and competition matters. Our team includes former U.S. federal prosecutors and international competition specialists, all supported by the resources of our global platform. We have the deep legal knowledge, wide-ranging experience, and global reach to address your antitrust litigation, cartel defense, or merger clearance needs.
Our antitrust litigators have established a national reputation for helping our clients succeed in today’s increasingly complex regulatory environment. We have handled civil antitrust cases in more than 35 states and territories in the last decade. We are particularly experienced in multi-district class actions, defending price fixing, vertical and horizontal restraints, exclusionary conduct, tying arrangements, boycotts, monopolization, and other alleged trade restraints. In addition, Paul Hastings is one of the only firms in the world with lawyers in its merger clearance practice who have successfully tried multiple merger cases before the U.S. federal courts.
About Analysis Group
Analysis Group is one of the largest economics consulting firms, with more than 850 professionals across 14 offices in North America, Europe, and Asia. Since 1981, we have provided expertise in economics, finance, health care analytics, and strategy to top law firms, Fortune Global 500 companies, and government agencies worldwide. Our internal experts, together with our network of affiliated experts from academia, industry, and government, offer our clients exceptional breadth and depth of expertise.
ThomannFischer is one of the leading European commercial law boutiques with a strong emphasis on intellectual property, technology and competition law. The firm, founded in 1998, provides reliable support to both nationally and internationally (multinationally) operating clients covering all aspects of commercial and IP/IT law. The firm’s long tradition and history in high level of competence and commitment to quality and client service combined with a strong IP practice belongs to the characteristics of ThomannFischer. All of the firm's partners have a long history of professional experience and comprehensive knowledge in their areas of practice combining exceptional legal expertise for all business sectors where technology and commercial aspects constitute a key issue.